Glucagon-like peptide-1 analogues: a new way to quit smoking
So by reducing the influence of PBMs, increasing transparency and empowering patients to compare prices directly, we could move toward a market thats both more affordable and fair, but without structural changes to the rebate system and better protection for patients with chronic conditions, affordability will remain out of reach for many, but Im not the expert
This initial dose is considered a tolerability dose rather than a therapeutic dose for most patients
Avoid high-fat, greasy foods that slow digestion even more
In the meantime, if youd like to learn more about Evaluates data in the GLP-1 space, you can get in touch here.
There's a family focus on eating less while increasing protein, but she says the biggest change isn't physical